How should I store my GLP-1 medication after opening
Polycystic ovary syndrome: causes
Oral minoxidil prescribed off-label for hair loss may qualify under some plans, depending on specific policy language
At the same time, Medicare announced it would begin expanding GLP-1 coverage, launching demonstration programs that will make these medications available at federally negotiated prices to beneficiaries with obesity and related comorbidities as early as this summer
The broad, shortage-based compounding pathway ended after the FDA resolved the semaglutide and tirzepatide shortages, and in April 2026 the FDA proposed excluding these drugs from the 503B outsourcing-facility bulks list, with a comment period through June 29, 2026
doi: 10.2139/ssrn.3646583 69 VajaR.ChanJ